Skip to content
Home/Companies/Biotech/Alveus Therapeutics
Alveus Therapeutics

Alveus Therapeutics

Biotech·US·Active·New
Entry
2026
Hold
New
Status
Active

Who owns Alveus Therapeutics?

Alveus Therapeutics is currently owned by Jeito Capital through Jeito II (2026 vintage), since 2026. Across its history, Alveus Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Jeito Capital
Most recent investor
Jeito Capital
Jeito II · 2026 · VC
2 ownership periods · full history below

Key facts

HQFrance
SectorBiotech
Websitewww.alveus.eu

Ownership history

2 ownership periods

Active
Co-held by Andera Partners and Jeito Capital since 2026.
Andera Partners
Andera PartnersActive
2026 · present(<1yr) · BioDiscovery 7 · 2025 · VC
Jeito Capital
Jeito CapitalActive
2026 · present(<1yr) · Jeito II · 2026 · VC

More from Jeito II

Other portfolio companies in the same fund.

Adcendo
Adcendo
Active
BiotechDenmark· 2026
Bionyra Pharma
Active
BiotechFrance· 2026
Augustine Therapeutics
Augustine Therapeutics
Active
BiotechBelgium· 2025
Azafaros
Azafaros
Active
BiotechNetherlands· 2025
Callio Therapeutics
Active
BiotechUS· 2025
Odyssey Therapeutics
Active
BiotechUS· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Alveus Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Alveus Therapeutics?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Alveus Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue